My watch list
my.bionity.com  
Login  

8,291 Current news from the industry pharma

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

image description
Merck and Baylor College of Medicine Collaborate to Advance a Vaccine Manufacturing Platform to Fight Covid-19

Company will focus on process development and improvements for manufacturing Baylor’s Covid-19 vaccine candidates

28-May-2020

Merck and Baylor College of Medicine, Houston, Texas, USA, announced an extension of their ongoing collaboration to advance a manufacturing platform to fight Covid-19, designed to accelerate transition to Phase 1 clinical trials. “Vaccine manufacturing is extremely complicated, so we are ...

more

image description
Vienna vaccine start-up to be acquired by MSD

Acquisition is expected to accelerate the development of a COVID-19 vaccine candidate

27-May-2020

Themis and MSD (trademark of Merck & Co., Inc.) announced that the companies have entered into a definitive agreement under which MSD, through a subsidiary, will acquire privately-held Themis. Themis has a broad pipeline of vaccine candidates and immune-modulatory therapies developed using its ...

more

image description
Public Value Carries Startups Through the Crisis

"Those who solve relevant problems will prevail"

26-May-2020

Every year, HHL Leipzig Graduate School of Management and the auditing firm Ernst & Young (EY) hand out awards to young companies offering solutions for societal challenges through their products and services and creating public value. Some of the startups which received one of the coveted the ...

more

image description
Eppendorf significantly expands capacities for the production of consumables

Strong capacity expansion by 30 percent from 2021

15-May-2020

The Eppendorf Group is expanding its production capacity at the Oldenburg in Holstein site in Germany by building two additional production halls. As a result, Eppendorf Polymere GmbH, a wholly owned subsidiary ofEppendorf AG, will increase its total capacity by around 30 percent from 2021. A ...

more

image description
CureVac's coronavirus vaccine candidate shows positive pre-clinical results at low dose

First phase 1/2a clinical trial in healthy volunteers in June 2020 planned

15-May-2020

CureVac AG announced positive pre-clinical results at a low dose for its lead vaccine candidate against the novel Coronavirus (SARS-CoV-2). The data showed a fast induction of a balanced immune response with high levels of virus neutralizing titers (VNTs) and T-cell responses. VNTs are a major ...

more

image description
Prostate cancer treatment may protect from COVID-19

Even if men did not have prostate cancer could take androgen-​deprivation therapies to prevent infection

11-May-2020

Androgen-​deprivation therapy could protect against infection with SARS-​CoV-2 and against severe disease progression. This is suggested by a study led by a professor from the Università della Svizzera Italiana and ETH Zurich. Male cancer patients have a 1.8-​fold increased risk of COVID-​19 ...

more

image description
Are the high prices of cancer drugs justified?

Does the cost correspond to the particular drug’s effectiveness in combating the disease?

05-May-2020

Do high prices of some cancer medicines have a higher benefit than those drugs with lower prices? An international UZH study has concluded that, in general, there is no correlation between costs of a cancer drugs and their clinical benefit. The researchers are therefore calling for the clinical ...

more

image description
Evotec to collaborate with Ology Bioservices on antibodies against Coronavirus

Antibodies were generated from convalescing COVID-19 patients

04-May-2020

Evotec SE announced that its Seattle-based subsidiary Just – Evotec Biologics, Inc. has entered into a partnership with Ology Bioservices, Inc. (Ology Bio) for the evaluation and analytical characterisation of antibodies against SARS-CoV-2. This work falls under a contract awarded to Ology Bio by ...

more

Marinomed receives funding to research SARS-CoV-2 therapy

29-Apr-2020

Marinomed Biotech AG receives funding from the Austrian Research Promotion Agency (FFG) for the development of a SARS-CoV-2 therapy based on Carragelose®. The aim of the project is to clinically test an inhalation solution as an acute treatment for viral pneumonia caused by SARS-CoV-2 or other ...

more

Bayer: Good start to 2020

Activities marked by COVID-19

27-Apr-2020

The Bayer Group has registered a good start to 2020, with business activities in the first quarter greatly marked by the COVID-19 pandemic. “With our life science product portfolio in the areas of health and nutrition, we have shown our ability to successfully continue our business operations in ...

more

Page 1 From 830
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE